GLAXO

GlaxoSmithKline Pharmaceuticals Ltd. or GSK Rx India was established in 1924 in India. It is one of the oldest pharmaceutical companies and employs over 3,500 people. Globally, the company is around £28.4 billion, and it is leading research-based healthcare and pharmaceutical companies. In India, it is one of the market leaders with an approximate turnover of INR 2080 crore and a share of 5.1%. The Company is also one of the world's leading research-based pharmaceutical and healthcare companies. It is committed to enhancing the quality of human life by enabling people to do more, feel better, and live longer.

The company leads in many therapeutic segments such as dermatology, anti–hermeneutics, and hormones. It has 7 products in the top 50 brands, and the top five GSK products are Augmentin, Calpol, Ceftum, Phexin, and Betnesol. The company's vaccines division is ranked first in a fast-growing vaccines market. Some leading products in India are Havrix, Varilrix, Rotarix, Hiberix, and Cervarix.

GSK India's R&D centers at Thane and Nashik have been granted recognition by the Department of Scientific and Industrial Research, Government of India. The number of clinical studies conducted in India is rapidly growing across a range of therapy areas. The company's social responsibility programs focus on the development of underdeveloped villages, women, children, and age, specifically in the areas of healthcare and education.

The GSK India product portfolio also includes prescription medicines and vaccines, and prescription medicines also range across therapeutic areas. It includes anti-infectives, dermatology, gynecology, diabetes, cardiovascular disease, oncology, and respiratory diseases. The GSK India is the market leader in the therapeutic categories in which it operates. GSK also offers a range of vaccines, for the prevention of hepatitis A, hepatitis B, invasive disease caused by H, influenza, chickenpox, diphtheria, pertussis, tetanus, rotavirus, cervical cancer, and others.

The company's best–in–class field force, backed by a nationwide network of stockiest, ensures that the Company's products are readily available across the nation. The company also has 2 manufacturing units in India that are located at Nashik and Thane as well as a clinical development center in Bangalore. Also, the state of art plant at Nashik makes formulations while bulk drugs and the active pharmaceutical ingredients are manufactured at Thane.

The GSK India product portfolio includes prescription medicines and vaccines and it is also a market leader in most of the prescription medicines such as: